Last updated: August 2026
Global rank: Worldwide · 2026-08
#8,529
AI visibility: Grade A+
94
SEO health: Latest audit
86
Visits
192.4K
per month, estimated
Keywords
12.1K
ranking in Google
Organic share
100%
192.4K organic visits
LLMS.txt
Published
170 lines AI engines can read
You're seeing the free preview of bms.com
bms.com Web Traffic Statistics
Key findings
- Bristol Myers Squibb (Biopharmaceuticals) is ranked #8,529 worldwide in our August 2026 domain ranking, inside the top 10,000, down 580 places from #7,949 in July 2026.
- It is estimated to receive about 192,400 visits a month from search, 100% of it organic, across 12,100 ranking keywords.
- Its AI visibility score is 94 out of 100 (grade A+), with a published llms.txt of 170 lines.
- Its last technical audit scored 86/100, with "Optimize Page Load Speed" the highest-priority fix.
| Month | Rank | Move |
|---|---|---|
| August 2026 | #8,529 | ▼ 580 |
| July 2026 | #7,949 | ▼ 1,079 |
| June 2026 | #6,870 | — |
| May 2026 | #6,870 | ▼ 2,430 |
| April 2026 | #4,440 | ▲ 2,136 |
| March 2026 | #6,576 | ▼ 435 |
| February 2026 | #6,141 | — |
What this company does
Bristol Myers Squibb stands as a global biopharmaceutical powerhouse, relentlessly pursuing breakthrough therapies for patients grappling with tough diseases like cancer, immunology disorders, and cardiovascular conditions. From their labs emerge innovative drugs that don't just treat symptoms but target the root causes, offering real hope where options were once slim. They pour massive resources into research and de…
Our read on the site
The overall SEO health of bms.com is strong, with a good performance score of 72/100 and a solid SEO score of 85/100. However, there are several content gaps and technical improvements that can enhance visibility and user experience.
bms.com Traffic and Visitor Engagement
Search engines send bms.com an estimated 192,400 visits a month. Effectively all of it is organic — about 192,400 visits from unpaid results. Paid search contributes only about 14 visits a month. Spread across 12,100 ranking keywords, that averages roughly 16 organic visits per keyword.
Monthly visits
192.4K
Latest estimate
Change
No monthly history yet
It starts building from the first scan
Organic visits
192.4K
100% of all traffic
Paid visits
14
0.01% of its search traffic
Organic vs paid
100%
0%
We don't hold a month-by-month history for this domain yet.
The traffic dashboard builds one from the first scan onwards.
bms.com AI Visibility
bms.com scores 94 out of 100 on our AI visibility scale, grade A+. It takes full marks for LLMS.txt, Crawlability and Structured data. The biggest gap is Company profile, at 22 of 25 points (7/8 core fields), worth 3 points if closed. It also loses points on SEO health (17/20).
Grade A+
Scored from this domain's own data — llms.txt, profile completeness, technical health, crawlability and structured data.
Present
7/8 core fields
85/100
robots ✓ · sitemap ✓
Detected
Fix these first
- → Complete your company profile so AI answers about you stay accurate.
bms.com LLMS.txt
The llms.txt on bms.com runs to 170 lines (8,429 characters) across 12 sections, last generated in April 2026. It introduces the site as "Bristol Myers Squibb". It tells AI engines the business works in Biopharmaceuticals, Oncology, Immunology, Hematology and Cardiovascular. It describes 5 products, including Opdivo, Eliquis and Yervoy. Services it lists include Clinical Trials, Patient Support Programs, Healthcare Professional Resources and Drug Development Partnerships. The audience it names is Patients with serious diseases, oncologists, researchers, aged Adults 40+ (Global). Technologies it mentions include HTTPS Security, Viewport Optimization, Robots.txt, XML Sitemap and SEO Tools. The keywords it claims start with "biopharmaceutical", "medicines", "clinical trials" and "patient support". It gives the company type as Public.
Status
Published
AI engines can read it
Lines
170
In the file
Size
8.4K
Characters
Sections
12
Updated Apr 28, 2026
What the file says
# Bristol Myers Squibb ## About Bristol Myers Squibb drives the future of medicine by discovering, developing, and delivering game-changing therapies for serious illnesses. Their work spans oncology, where immunotherapies like Opdivo rally the immune system against cancer; hematology, tackling blood cancers with precision; immunology, easing autoimmune battles; and cardiovascular care, preventing strokes and clots. Every step prioritizes patients, from early research through global launches. They run thousands of clinical trials, inviting diverse participants to shape safer, smarter drugs. Patient support goes beyond meds, offering navigation tools, financial aid, and community connections. Innovation thrives via hefty R&D budgets, AI integrations, and partnerships that spark breakthroughs. Healthcare pros get robust data and training to optimize treatments. They've touched millions, extending lives and improving quality amid dire diagnoses. Sustainability weaves in, with eco-friendly production and ethical sourcing. Global teams adapt therapies to local needs, bridging disparities. Leadership fosters a bold culture where science meets compassion. Milestones like the Celgene buyout supercharged their pipeline. Trust builds on transparency, from trial results to access programs. They challenge healthcare norms, pushing personalized medicine frontiers. Employees number over 35,0
Sections in the file
Areas of work
Keywords it claims
Technologies
Products it tells AI about
- OpdivoPrescription only
- EliquisPrescription only
- YervoyPrescription only
- OrenciaPrescription only
- SprycelPrescription only
Services it tells AI about
- Clinical Trials
- Patient Support Programs
- Healthcare Professional Resources
- Drug Development Partnerships
- Personalized Medicine Consulting
Competitors it names
Audience it targets
Patients with serious diseases, oncologists, researchers · Adults 40+ · Global
Company type
Public
bms.com Organic Keywords
Google lists bms.com for about 12,100 keywords, which together bring an estimated 192,400 organic visits a month.
Ranking keywords
12.1K
Found in Google for this domain
Visits they bring
192.4K
Estimated organic visits a month
Top ranking keywords
No ranked-keyword data cached for this domain yet.
Ranked Keywords pulls the full list on its first run.
What it ranks for
bms.com SEO Audit
The latest technical audit of bms.com scored 86 out of 100 overall. Performance is its weakest area at 72, while accessibility scores highest at 89. The audit makes 12 recommendations in all, and 2 of the 4 listed first are rated high priority or critical.
Overall
SEO
Performance
Accessibility
Fix these first
- CriticalOptimize Page Load Speed
- HighEnhance Mobile Responsiveness
- MediumImplement llms.txt
- MediumUpdate Meta Descriptions
8 more recommendations, with the exact changes and the pages they apply to, are in the full report.
bms.com Competitors and Alternatives
Bristol Myers Squibb's company profile names https://www.amgen.com, https://www.abbvie.com, https://www.merck.com and https://www.janssen.com as competitors. Its own llms.txt adds https://www.gilead.com and https://www.eli-lilly.com. Outside its market, the domains ranked closest to it in our worldwide ranking are weatherspark.com, nefisyemektarifleri.com, g4media.ro and ampaeservices.com.
bms.com Company Profile
Bristol Myers Squibb stands as a global biopharmaceutical powerhouse, relentlessly pursuing breakthrough therapies for patients grappling with tough diseases like cancer, immunology disorders, and cardiovascular conditions. From their labs emerge innovative drugs that don't just treat symptoms but target the root causes, offering real hope where options were once slim. They pour massive resources into research and de…
Founded in 1989 (about 37 years ago), Bristol Myers Squibb is based in New York, United States. Its workforce is listed as more than 10,001 employees. Its profile files it under Biopharmaceuticals, with further tags for Oncology, Immunology and Clinical Trials. Products on record for it: Opdivo (nivolumab - immunotherapy for cancer), Yervoy (ipilimumab - checkpoint inhibitor), Eliquis (apixaban - anticoagulant) and Orencia (abatacept - rheumatoid arthritis). Reported revenue is $45B (2023), and total funding is listed at Publicly Traded. Its tagline reads: "Pioneering medicines that change patients' lives".
- Sector
- Biopharmaceuticals
- Headquarters
- New York, United States
- Founded
- 1989
- Employees
- 10,001+
- Revenue
- $45B (2023)
- Funding
- Publicly Traded
- Products
- Opdivo (nivolumab - immunotherapy for cancer), Yervoy (ipilimumab - checkpoint inhibitor), Eliquis (apixaban - anticoagulant), Orencia (abatacept - rheumatoid arthritis)
bms.com Traffic by Country
Which markets this brand actually serves, and where the web links to it from.
Top customer markets
AI estimate · live webWe only measure visitor geography for domains whose analytics are connected to us. For everyone else this is read live from the web and shown as an estimate — never mixed in with the measured numbers.
No market breakdown available for this brand.
Where its backlinks come from
Measured. The country each linking site is hosted in — a real signal of which regions know this brand.
No backlink sample for this domain yet.
Backlink Analytics collects one on its first run.
bms.com Backlink Analytics
Who vouches for this domain. Strong, varied links are still the clearest signal of authority — to search engines and to AI engines that cite sources.
We haven't run a backlink crawl for bms.com yet, so there are no link counts to show. Backlink Analytics builds the profile on its first run and it appears here after that.
—
links on file
Companies ranked next to bms.com
Neighbours of #8,529 in our worldwide ranking — each with its own report.
Wait — let's zoom out.
You are looking at one domain. bms.com competes in a market, and the same numbers exist for everyone in it — including the sites AI engines recommend instead of yours. Amrut.ai reads all of them, so you can see who is winning, why, and what to change first.
Everything above, for your own domainand the plan to fix it
Run the free scan on your site and get its AI visibility score, its gaps, and the exact next steps.
Look up another company
A brand name or a domain — the whole overview loads in seconds.